Skip to main content

#153986

Anti-SUMO-2/SUMO-3 (8A2)

Cat. #153986

Anti-SUMO-2/SUMO-3 (8A2)

Cat. #: 153986

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: SUMO-2 and SUMO-3 but does not recognize SUMO-1

Class: Monoclonal

Application: ChIP ; IHC ; IF ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Michael Matunis

Institute: Johns Hopkins University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-SUMO-2/SUMO-3 (8A2)
  • Alternate name: Small ubiquitin-related modifier 2; HSMT3; SMT3 homolog 2; SUMO-3; Zentrin-2; Ubiquitin-like protein SMT3B; Smt3B
  • Research fields: Apoptosis and autophagy;Biochemistry;Cell biology;Cell signaling and signal transduction;Genetics
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ChIP ; IHC ; IF ; IP ; WB
  • Description: Small ubiquitin-like modifiers (SUMO) post-translationally modify proteins by a process called SUMOylation. There are three SUMO proteins expressed in vertebrates, SUMO-2 and SUMO-3 are ~95% identical to each other (SUMO-2/3), but they are only ~45% identical to SUMO-1. Consequently, SUMO-2/3 have unique targets and functions compared to SUMO-1. For instances SUMO-2/3 can form polymeric chains and SUMO-1 cannot. SUMOylation on lysine residues regulates various cellular processes including nuclear transport, DNA replication and repair, transcription, protein stability, mitochondrial fission, signal transduction, mitosis and apoptosis.
  • Immunogen: Full length human recombinant protein of SUMO-2
  • Isotype: IgG

Target Details

  • Target: SUMO-2 and SUMO-3 but does not recognize SUMO-1
  • Target background: Small ubiquitin-like modifiers (SUMO) post-translationally modify proteins by a process called SUMOylation. There are three SUMO proteins expressed in vertebrates, SUMO-2 and SUMO-3 are ~95% identical to each other (SUMO-2/3), but they are only ~45% identical to SUMO-1. Consequently, SUMO-2/3 have unique targets and functions compared to SUMO-1. For instances SUMO-2/3 can form polymeric chains and SUMO-1 cannot. SUMOylation on lysine residues regulates various cellular processes including nuclear transport, DNA replication and repair, transcription, protein stability, mitochondrial fission, signal transduction, mitosis and apoptosis.

Applications

  • Application: ChIP ; IHC ; IF ; IP ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Storage conditions: -20° C
  • Shipping conditions: Dry ice

References

  • Zhang et al. 2008. Mol Cell. 29(6):729-41. PMID: 18374647.
  • SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.